Beauty Farm Medical and Health Industry Inc. disclosed a Next Day Disclosure Return dated 29 May 2026, confirming the on-market buyback of 20,000 ordinary shares on the Hong Kong Stock Exchange. The shares were repurchased at prices ranging from HK$18.53 to HK$19.05, for a total cash outlay of HK$0.38 million, implying a volume-weighted average cost of HK$18.81 per share. All repurchased shares have been retained as treasury shares.

Following the transaction, the company’s treasury stock increased from 2.30 million to 2.32 million shares, while the number of issued shares excluding treasury shares fell marginally to 249.27 million. The aggregate share count, including treasury shares, remains unchanged at 251.59 million.

The latest buyback forms part of the repurchase mandate approved on 27 June 2025, which authorises the company to repurchase up to 23.58 million shares. To date, 2.32 million shares—equivalent to 0.99% of the issued share capital at the time the mandate was granted—have been repurchased under this authorisation.

Pursuant to Hong Kong listing rules, Beauty Farm Medical is subject to a moratorium on issuing, selling or transferring any shares for 30 days following this repurchase, ending on 28 June 2026.